Recent studies suggest that a progestin-induced withdrawal bleed may reduce conception and live birth rates in women undergoing ovulation induction with clomiphene citrate.
Hormonal and Bleeding Disorders
An inexpensive generic drug has been found to prevent hemorrhaging in women after childbirth.
Could alcohol consumption have an impact on breast cancer screening? Plus, how has the HPV vaccine impacted CIN2+ rates. And: Can metformin plus changes in lifestyle mitigate PCOS.
According to a new study in Gynecologic Oncology, women who have polycystic ovary syndrome (PCOS) may be at greater risk of developing some types of cancer.
A study in The New England Journal of Medicine funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development suggests that letrozole may be more effective at helping women with polycystic ovary syndrome (PCOS) become pregnant than clomiphene.
PCOS is likely underdiagnosed, especially in adolescent patients. It is challenging to make a diagnosis during the 1–2 years following menarche because normal pubertal changes can mimic features of PCOS.
Results of a study of more than 116,000 women, published online May 14 in Human Reproduction reveal a 39% lower risk of endometriosis in those who were morbidly obese than in women with normal body mass index (BMI).